The defining histopathological features of ALS are upper (corticospinal tract) and lower (anterior horn of the spinal cord) motor neuron degeneration in association with abnormal protein aggregation.1-3 A complex array of neurodegenerative mechanisms leading to neuronal death are implicated in ALS, including glutamate excitotoxicity, oxidative stress, mitochondrial dysfunction, inflammation, and axonal transport disruption.4 TDP-43 pathology is thought to be central in ALS – hyperphosphorylated, ubiquitinated TDP-43 neuronal inclusions are observed in ~97% of cases.5
While there are currently numerous candidates under investigation, there are not yet currently any fluid or imaging biomarkers validated for routine clinical use6